Literature DB >> 12186806

Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer.

Costanza Emanueli1, Maria B Salis, Alessandra Pinna, Tiziana Stacca, Anna F Milia, Alessandra Spano, Julie Chao, Lee Chao, Luigi Sciola, Paolo Madeddu.   

Abstract

BACKGROUND: Microvascular insufficiency represents a major cause of end-organ failure among diabetics. METHODS AND
RESULTS: In streptozotocin-induced diabetic mice, we evaluated the potential of human tissue kallikrein (hTK) gene as a sole therapy against peripheral microangiopathy. Local delivery of hTK gene halted the progression of microvascular rarefaction in hindlimb skeletal muscle by inhibiting apoptosis, thus ensuring an improved hemodynamic recovery in case of supervening vascular occlusion. The curative action of hTK did not necessitate insulin supplementation. Application of gene therapy at a stage of established microangiopathy stimulated vascular regeneration.
CONCLUSIONS: Our studies indicate that hTK may represent a useful tool for the treatment of microvascular complications in diabetics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12186806     DOI: 10.1161/01.cir.0000027104.33206.c8

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic mice.

Authors:  Marco Meloni; Betty Descamps; Andrea Caporali; Lorena Zentilin; Ilaria Floris; Mauro Giacca; Costanza Emanueli
Journal:  Diabetes       Date:  2012-01       Impact factor: 9.461

2.  Application of transcutaneous carbon dioxide improves capillary regression of skeletal muscle in hyperglycemia.

Authors:  Tomohiro Matsumoto; Masayuki Tanaka; Takuya Ikeji; Noriaki Maeshige; Yoshitada Sakai; Toshihiro Akisue; Hiroyo Kondo; Akihiko Ishihara; Hidemi Fujino
Journal:  J Physiol Sci       Date:  2018-11-26       Impact factor: 2.781

3.  Terminal arteriolar network structure/function and plasma cytokine levels in db/db and ob/ob mouse skeletal muscle.

Authors:  Melissa K Georgi; Jacqueline Vigilance; Anthony M Dewar; Mary D Frame
Journal:  Microcirculation       Date:  2011-04       Impact factor: 2.628

4.  Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles.

Authors:  Andrea Caporali; Elisabetta Pani; Anton J G Horrevoets; Nicolle Kraenkel; Atsuhiko Oikawa; Graciela B Sala-Newby; Marco Meloni; Brunella Cristofaro; Gallia Graiani; Aurelie S Leroyer; Chantal M Boulanger; Gaia Spinetti; Sung Ok Yoon; Paolo Madeddu; Costanza Emanueli
Journal:  Circ Res       Date:  2008-06-19       Impact factor: 17.367

5.  Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway.

Authors:  Yu-Yu Yao; Hang Yin; Bo Shen; Robert S Smith; Yuying Liu; Lin Gao; Lee Chao; Julie Chao
Journal:  Cardiovasc Res       Date:  2008-08-09       Impact factor: 10.787

6.  Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice.

Authors:  M B Salis; G Graiani; E Desortes; R B Caldwell; P Madeddu; C Emanueli
Journal:  Diabetologia       Date:  2004-06-08       Impact factor: 10.122

7.  Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization.

Authors:  Oliver A Stone; Christine Richer; Costanza Emanueli; Vincent van Weel; Paul H A Quax; Rajesh Katare; Nicolle Kraenkel; Paola Campagnolo; Luciola S Barcelos; Mauro Siragusa; Graciela B Sala-Newby; Danila Baldessari; Marina Mione; Marie P Vincent; Andrew V Benest; Ayman Al Haj Zen; Julien Gonzalez; David O Bates; Francois Alhenc-Gelas; Paolo Madeddu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-01-22       Impact factor: 8.311

8.  Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of Type 1 diabetic mice.

Authors:  G Graiani; C Emanueli; E Desortes; S Van Linthout; A Pinna; C D Figueroa; L Manni; P Madeddu
Journal:  Diabetologia       Date:  2004-05-26       Impact factor: 10.122

9.  Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy.

Authors:  Dirk Westermann; Thomas Walther; Konstantinos Savvatis; Felcicitas Escher; Meike Sobirey; Alexander Riad; Michael Bader; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Diabetes       Date:  2009-03-10       Impact factor: 9.461

Review 10.  Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.

Authors:  Gaia Spinetti; Nicolle Kraenkel; Costanza Emanueli; Paolo Madeddu
Journal:  Cardiovasc Res       Date:  2008-02-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.